Tokyo, Japan

Hajime Karasuyma

This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hajime Karasuyma. Retrieved from https://idiyas.com/inventor/hajime-karasuyma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hajime Karasuyma: Innovator in Recombinant Protein Research

Introduction

Hajime Karasuyma is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant proteins. His work has implications for various therapeutic applications, especially in immunology.

Latest Patents

Karasuyma holds a patent for a recombinant protein receptor for IL-2. The present invention is directed to recombinant IL-2R.mu. protein or fragments thereof, cDNA coding therefore, vectors containing this cDNA, hosts transfected by these vectors, and monoclonal antibodies to the encoded recombinant IL-2R.mu. protein or fragments thereof. This innovation showcases his expertise in molecular biology and protein engineering.

Career Highlights

Hajime Karasuyma is currently employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His role involves research and development in the field of biopharmaceuticals, where he applies his knowledge to create novel therapeutic solutions.

Collaborations

Some of his notable coworkers include Masanori Hatakeyama and Takeshi Doi. Their collaborative efforts contribute to advancing research in the biotechnology sector.

Conclusion

Hajime Karasuyma's work in recombinant protein research exemplifies the innovative spirit of modern science. His contributions are paving the way for new therapeutic approaches in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…